Andreas du Bois Selected Research

Andreas du Bois Research Topics

Disease

100	Ovarian Neoplasms (Ovarian Cancer) 02/2022 - 09/2003
72	Neoplasms (Cancer) 04/2022 - 08/2004
33	Ovarian Epithelial Carcinoma 05/2022 - 03/2006
26	Breast Neoplasms (Breast Cancer) 05/2022 - 08/2004
20	Carcinoma (Carcinomatosis) 04/2022 - 04/2005
8	Neutropenia 01/2018 - 07/2011
7	Residual Neoplasm 01/2022 - 12/2006
7	Neoplasm Metastasis (Metastasis) 10/2021 - 01/2008
7	Disease Progression 01/2020 - 01/2005
6	Hypertension (High Blood Pressure) 11/2020 - 12/2011
5	Ascites 01/2022 - 12/2006
5	Diarrhea 01/2019 - 04/2007
4	Fatigue 11/2020 - 10/2014
4	Thrombocytopenia (Thrombopenia) 01/2018 - 10/2014
3	Genomic Instability 02/2022 - 07/2010
3	Anemia 11/2020 - 01/2016
3	Alopecia (Baldness) 01/2020 - 05/2015
3	Vulvar Neoplasms (Vulvar Cancer) 01/2020 - 03/2015
3	Fallopian Tube Neoplasms 01/2016 - 04/2007
2	Nausea 11/2020 - 01/2020
2	Vomiting 11/2020 - 01/2020
2	Sepsis (Septicemia) 01/2018 - 01/2016
2	Sarcoma (Soft Tissue Sarcoma) 11/2016 - 03/2016
2	Endometrial Neoplasms (Endometrial Cancer) 12/2015 - 09/2009
2	Endometrioid Carcinoma 04/2014 - 01/2008
2	Body Weight (Weight, Body) 12/2011 - 04/2009
2	Pathologic Complete Response 09/2011 - 04/2010
2	Lung Neoplasms (Lung Cancer) 07/2011 - 11/2010
2	Adenocarcinoma 11/2010 - 01/2008
1	Endometriosis 01/2022
1	Turcot syndrome 01/2022
1	Proteinuria 11/2020
1	Hemorrhage 11/2020
1	Pain (Aches) 10/2020
1	Dyspnea (Shortness of Breath) 08/2020
1	Hypesthesia (Numbness) 08/2020

Drug/Important Bio-Agent (IBA)

38	PlatinumIBA 04/2022 - 04/2005
26	Paclitaxel (Taxol)FDA LinkGeneric 02/2022 - 09/2003
24	Carboplatin (JM8)FDA LinkGeneric 02/2022 - 09/2003
20	taxaneIBA 04/2022 - 08/2004
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2009
10	Pharmaceutical PreparationsIBA 01/2018 - 01/2005
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2013 - 08/2004
9	AnthracyclinesIBA 11/2016 - 01/2005
8	Epirubicin (Ellence)FDA LinkGeneric 07/2013 - 08/2004
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2008
7	Hormones (Hormone)IBA 10/2021 - 04/2005
7	Bevacizumab (Avastin)FDA Link 11/2020 - 12/2011
7	liposomal doxorubicin (Doxil)FDA Link 01/2020 - 01/2010
7	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2005
7	Trastuzumab (Herceptin)FDA Link 09/2011 - 04/2009
6	Gemcitabine FDA Link 01/2020 - 10/2006
6	Docetaxel (Taxotere)FDA Link 11/2011 - 04/2005
5	Biological ProductsIBA 01/2020 - 10/2010
5	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2016 - 04/2005
4	Estrogen ReceptorsIBA 05/2022 - 06/2007
4	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2009
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2020 - 07/2010
4	Messenger RNA (mRNA)IBA 01/2019 - 01/2016
4	Topotecan (Hycamtin)FDA LinkGeneric 01/2018 - 08/2006
4	pazopanib FDA Link 01/2018 - 10/2014
4	human ERBB2 proteinIBA 09/2011 - 01/2009
4	Capecitabine (Xeloda)FDA Link 04/2010 - 04/2009
4	Cisplatin (Platino)FDA LinkGeneric 10/2006 - 09/2003
3	nintedanibIBA 02/2022 - 01/2016
3	Biological FactorsIBA 10/2021 - 03/2009
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2020 - 07/2010
3	pertuzumabIBA 01/2019 - 01/2016
3	Transcription Factors (Transcription Factor)IBA 01/2015 - 02/2014
3	1-dodecylpyridoxal (PLD)IBA 12/2013 - 01/2010
3	abagovomabIBA 03/2011 - 12/2008
2	AlbuminsIBA 01/2022 - 09/2015
2	ChromatinIBA 01/2022 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 09/2012
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2016 - 01/2016
2	lonafarnib (SCH 66336)IBA 11/2015 - 08/2012
2	Tyrosine Kinase InhibitorsIBA 12/2013 - 01/2005
2	EnzymesIBA 12/2013 - 07/2010
2	Cytochrome P-450 CYP2C8IBA 05/2013 - 07/2011
2	Poly Adenosine Diphosphate RiboseIBA 06/2011 - 07/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2009 - 06/2007
2	Gefitinib (Iressa)FDA Link 04/2007 - 01/2005
2	Indicators and Reagents (Reagents)IBA 10/2006 - 01/2005
1	Aromatase InhibitorsIBA 05/2022
1	Letrozole (Femara)FDA LinkGeneric 05/2022
1	Immune Checkpoint InhibitorsIBA 02/2022
1	Circulating Tumor DNAIBA 01/2022
1	Factor XIII (Coagulation Factor XIII)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 12/2021

Therapy/Procedure

55	Drug Therapy (Chemotherapy) 04/2022 - 09/2003
47	Therapeutics 05/2022 - 04/2005
18	Cytoreduction Surgical Procedures 01/2022 - 09/2005
16	Neoadjuvant Therapy 04/2022 - 11/2006
11	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 04/2010
4	Adjuvant Chemotherapy 07/2013 - 05/2009
3	Hyperthermic Intraperitoneal Chemotherapy 11/2018 - 01/2017
3	Combination Drug Therapy (Combination Chemotherapy) 11/2016 - 05/2007
2	Radiotherapy 10/2019 - 03/2015
1	Art Therapy 01/2020
1	Conservative Treatment 01/2020